Study of Bronchial Inflammation in Adolescent Smokers With and Without Obesity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators want to assess differences in lung function and bronchial inflammation of young smokers and non-smokers with (BMI \> 30) and without obesity (BMI \< 25)(4 patient groups). The aim of the study is to compare differences in lung function (VC, FEV1, VC/FEV1, metacholine challenge) and bronchial inflammation in relation with smoking history and levels of exhaled CO. For the latter the investigators will analyze the levels of IL-8, IL-6, TNF alpha and INF gamma and mRNA of LBP, TLR2 and TLR4 in sputum. Further, inflammatory markers e.g. low CRP and inflammatory cytokines levels in the blood will be investigated. The aim is to describe a early stage of chronic obstructive pulmonary disease caused by cigarette smoke in juvenile smokers, and the relationship between bronchial inflammation and obesity in adolescents.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study

NCT03049202

Chronic Obstructive Pulmonary Disease Emphysema Chronic Bronchitis +3 more

ACTIVE_NOT_RECRUITING

Bronchial Inflammation in Patients With Bronchiolithis Obliterans

NCT01633385

Bronchiolitis Obliterans

COMPLETED

LCI and Bronchial Inflammation in Patients With BO

NCT02495597

Bronchiolitis Obliterans

COMPLETED

A Study to Obtain Normal Values of Inflammatory Variables From Healthy Subjects

NCT00848406

Asthma Copd

COMPLETED

Clinical Features of Smoker Patients With Chronic Obstructive Pulmonary Disease

NCT04711629

Copd Smoking

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tobacco smoke is the crucial factor at the beginning and in the course of the bronchial inflammation leading to COPD. It has been shown that cigarette smoke in vitro leads to a MAP kinase and NF-κB-dependent increase of pro-inflammatory cytokines, and inhibits bacteria-induced expression of β-defensins. Several studies revealed an increase of inflammatory cytokines like IL-8 and TNF in the sputum of smokers. Further studies demonstrated an up regulation of LTB4 and LBP possibly due to the LPS derived from tobacco smoke. Hasday et al could show that up to 15 ng per cigarette LPS is released. In principle, the cigarette smoke exposure liked a mild LPS inhalation. In separate work, we could show that LPS inhalation in healthy non-smokers to an increase of CRP and LBP concentrations in the serum lead. In another study of adolescents, 24 smokers (age 17.7 years) and 24 non-smoking (age 17.5 years) were compared. The CO in smokers was significantly increased, and the NO concentrations decreased. At the same time there was a significantly greater bronchial hyperreagibility in the smoker group.

According to a recent study in Germany (KiGGS study), already 31% of the adolescents' boys and 32% of the girls do smoke. The social status is of great importance. Boys and girls from families with a low social status smoke more frequently than those from families with middle-and especially with higher social status. Similarly obesity is linked to the social status with overweight occurring more often in families with a lower social status.

A visceral obesity is closely associated with the risk of type-2-diabetes as well as other aspects of the metabolic syndrome. However, the existing insulin resistance is of fundamental importance. Due to increased visceral fat depots and subsequently increased release of proinflammatory proteins various complications do occur.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Tobacco Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

obese smokers

BMI \> 30 kg/m2 CO ≥ 15 ppm

No interventions assigned to this group

non-obese smokers

BMI \< 25 kg/m2 CO ≥ 15 ppm

No interventions assigned to this group

obese non-smokers

BMI \> 30 kg/m2 CO ≤ 6 ppm

No interventions assigned to this group

non-obese non-smokers

BMI \< 25 kg/m2 CO ≤ 6 ppm

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* informed consent
* age between 14 and 22 years
* smokers CO ≥ 15 ppm
* non-smokers CO ≤ 6 ppm

Exclusion Criteria

* Asthma \> GINA I°
* others chronic diseases or infections (e.x. HIV, tuberculosis, malignancy)
* pregnancy
* therapy with systemic corticosteroids
* permanent treatment with inhaled corticosteroids
* documented alcohol, substance, and/or drug abuse
* incapability to perform all study procedure

Minimum Eligible Age

14 Years

Maximum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes